Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1996 1
2000 2
2001 1
2002 4
2003 1
2004 1
2005 1
2006 2
2007 1
2008 2
2010 1
2011 2
2012 1
2013 6
2014 2
2015 5
2016 4
2017 2
2019 7
2020 12
2021 14
2022 6
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.
Mamounas EP, Untch M, Mano MS, Huang CS, Geyer CE Jr, von Minckwitz G, Wolmark N, Pivot X, Kuemmel S, DiGiovanna MP, Kaufman B, Kunz G, Conlin AK, Alcedo JC, Kuehn T, Wapnir I, Fontana A, Hackmann J, Polikoff J, Saghatchian M, Brufsky A, Yang Y, Zimovjanova M, Boulet T, Liu H, Tesarowski D, Lam LH, Song C, Smitt M, Loibl S. Mamounas EP, et al. Among authors: kuehn t. Ann Oncol. 2021 Aug;32(8):1005-1014. doi: 10.1016/j.annonc.2021.04.011. Epub 2021 Apr 28. Ann Oncol. 2021. PMID: 33932503 Free article. Clinical Trial.
A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.
Kuemmel S, Heil J, Rueland A, Seiberling C, Harrach H, Schindowski D, Lubitz J, Hellerhoff K, Ankel C, Graßhoff ST, Deuschle P, Hanf V, Belke K, Dall P, Dorn J, Kaltenecker G, Kuehn T, Beckmann U, Potenberg J, Blohmer JU, Kostara A, Breit E, Holtschmidt J, Traut E, Reinisch M. Kuemmel S, et al. Among authors: kuehn t. Ann Surg. 2022 Nov 1;276(5):e553-e562. doi: 10.1097/SLA.0000000000004572. Epub 2020 Nov 4. Ann Surg. 2022. PMID: 33156057
T.E.L.S. Supplemental Implant Verification.
Kuehn T, Nelson A. Kuehn T, et al. AORN J. 2020 Nov;112(5):546. doi: 10.1002/aorn.13201. AORN J. 2020. PMID: 33113188 No abstract available.
Quality indicators in breast cancer care.
Del Turco MR, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B, Decker T, Dietel M, Gentilini O, Kuehn T, Mano MP, Mantellini P, Marotti L, Poortmans P, Rank F, Roe H, Scaffidi E, van der Hage JA, Viale G, Wells C, Welnicka-Jaskiewicz M, Wengstöm Y, Cataliotti L. Del Turco MR, et al. Among authors: kuehn t. Eur J Cancer. 2010 Sep;46(13):2344-56. doi: 10.1016/j.ejca.2010.06.119. Epub 2010 Jul 31. Eur J Cancer. 2010. PMID: 20675120
Sentinel node mapping in gynecologic malignancies.
Kuehn T, Kreienberg R. Kuehn T, et al. Arch Gynecol Obstet. 2000 Nov;264(3):113-5. doi: 10.1007/s004040000131. Arch Gynecol Obstet. 2000. PMID: 11129507 No abstract available.
Fibrin Sealants and Axillary Lymphatic Morbidity: A Systematic Review and Meta-Analysis of 23 Clinical Randomized Trials.
Gasparri ML, Kuehn T, Ruscito I, Zuber V, Di Micco R, Galiano I, Navarro Quinones SC, Santurro L, Di Vittorio F, Meani F, Bassi V, Ditsch N, Mueller MD, Bellati F, Caserta D, Papadia A, Gentilini OD. Gasparri ML, et al. Among authors: kuehn t. Cancers (Basel). 2021 Apr 24;13(9):2056. doi: 10.3390/cancers13092056. Cancers (Basel). 2021. PMID: 33923153 Free PMC article. Review.
80 results